T1	SectionAnnotate 0 10	SUBJECTIVE
T2	SectionAnnotate 769 772	ROS
T4	SectionAnnotate 856 877	Past Medical History:
T5	SectionSkip 2703 5966	Pathology:  LEFT 3:30, 5cm FN (1.8cm mass): IDC. Grade 2. No LVI. l0 mm on core. ER 61-70%. PR negative. Ki-6715-20%. Her-2 negative by FISH  HER2 negative by FISH.  LEFT 3:30, 2.5cm FN (1.3cm mass): IDC. Grade 3. No LVI. 15 mm on core. ER 41-50%. PR 1-10%. Ki-67 30-40%.  HER2 negative by FISH. +LCIS focally.  RIGHT 11:00. 4cm FN (0.9cm mass): Sclerosing adenosis, negative for CA. Felt to be concordant.  -12/22/16: MRI breast - LEFT posterior lateral mass measures 2.4 x 2.5 x 2.9cm, abuts but does not invade the pectoralis major. Extends to within 2mm of overlying skin which is abnormally thickened and retracted, though no abnormal skin enhancement. LEFT anterior-medial smaller mass measures 1.6 x 1.3x 1.5cm. Highly suspicious lower outer (3:30-5:30) segmental nonmass enhancement inferior, medial and between both masses spanning a region 3.6 x 4.2 x 3cm. Few small inner left breast cysts. No axillary adenopathy. RIGHT breast with multiple cysts measuring up to 2.5cm in the outer breast and 3.lcm in the inner breast.  -01/06/17: Mammaprint - low  -01/08/17: CT CAP -  Enhancing mass in the left breast, no axillary, hilar, mammary LAD.  No distant mets  -01/10/17: MRI  LEFT Breast:  1) Index tumor: There are 
 two adjacent irregular masses with spiculated margins in the lower outer left breast, posterior depth, best seen on post gad axial image 77/***** and sagittal *****/*****, with a biopsy clip centered in each mass. Signal intensity/time curve demonstrates rapid initial rise and washout enhancement kinetics.    2) Additionally, there is asymmetric non-mass enhancement extending medially from the two index masses, concerning for DCIS. The overall span of the two adjacent masses and NME measures 34 x 32 x 28 mm.    3) There is a 5 mm oval mass in the outer central left breast, anterior depth, best seen on post gad axial image 66/*****. Signal intensity/time curve demonstrates rapid initial rise and washout enhancement kinetics. This mass is approximately 2 cm anterosuperior to the index masses.    RIGHT Breast:  1) There are 2 adjacent foci in the upper outer right breast, anterior depth. One is 4mm and is best seen on post gad axial image 57/*****. Signal intensity/time curve demonstrates rapid initial rise and plateau enhancement kinetics. The other is 3 mm and is best seen on post gad axial image 55/*****. Signal intensity/time curve demonstrates medium initial rise and persistent enhancement kinetics.    2) There is a post biopsy clip in the outer central right breast, middle depth, site of biopsy proven sclerosing adenosis, which was sampled at an outside facility. There is non-mass enhancement just medial to the biopsy clip, best seen on post gad axial image 69/*****, which is likely represents the sclerosing adenosis.  01/11/17: start tamoxifen    01/18/17: start zoladex injection    February 2017: switch from tamoxifen to letrozole  March 2017: d/c letrozole and switch back to tamoxifen September 13 depression  04/09/17:  bilateral mastectomies and left slnb: path pending  November 2018: stopped tamoxifen, switch to OS/letrozole    December 2018: switched from letrozle to exemestane due to anxiety and emotional lability, cont zoladex locally monthly        
 Polycystic ovaries 12/26/2016     Last
T9	SectionSkip 8580 8591	MEDICATIONS
T10	SectionSkip 8593 9609	Current Outpatient Medications   Medication Sig Dispense Refill    amoxicillin (AMOXIL) 875 mg tablet TAKE 1 TABLET BY MOUTH TWICE A DAY UNTIL GONE  0    amoxicillin-clavulanate (AUGMENTIN) 875-125 mg tablet Take by mouth.      benzonatate (TESSALON) 200 mg capsule Take 200 mg by mouth.      buPROPion (WELLBUTRIN XL) 150 mg 24 hr tablet Take 150 mg by mouth.      doxycycline (VIBRA-TABS) 100 mg tablet TAKE 1 TABLET BY MOUTH TWICE A DAY FOR 10 DAYS  0    exemestane (AROMASIN) 25 mg tablet TAKE 1 TABLET BY MOUTH EVERY DAY FOR 30 DAYS  4    HYDROcodone-acetaminophen (NORCO) 5-325 mg tablet TAKE 1 TO 2 TABS BY MOUTH EVERY 6 HOURS AS NEEDED FOR PAIN *G89*  0    IBU 800 mg tablet TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED  3    metroNIDAZOLE (METROGEL) 0.75 % gel Apply thin film to affected area BID      ondansetron (ZOFRAN-ODT) 4 mg rapid dissolve tablet DISSOLVE 1 TAB ON THE TONGUE EVERY 6 HOURS AS NEEDED FOR NAUSEA/VOMITING  0     No current facility-administered medications for this visit.
T14	SectionAnnotate 11165 11182	ASSESSMENT & PLAN
T15	PROBLEM 65 83	left breast cancer
T16	PROBLEM 85 127	mammaprint low risk IDC of the left breast
T17	TREATMENT 142 164	bilateral mastectomies
T18	TREATMENT 166 188	s/p adjuvant tamoxifen
T19	TREATMENT 272 281	letrozole
T20	TREATMENT 285 295	exemestane
T21	PROBLEM 317 324	anxiety
T22	PROBLEM 329 347	emotional lability
T23	TREATMENT 382 391	letrozole
T24	TREATMENT 431 441	exemestane
T27	TREATMENT 497 507	exemestane
T28	PROBLEM 519 538	minimal joint aches
T29	PROBLEM 541 557	mild hot flashes
T30	PROBLEM 562 570	insomnia
T31	PROBLEM 573 582	bone pain
T32	PROBLEM 585 600	vaginal dryness
T33	PROBLEM 685 712	new or concerning bone pain
T34	PROBLEM 714 717	sob
T35	PROBLEM 719 724	cough
T36	PROBLEM 726 734	abd pain
T37	PROBLEM 736 739	n/v
T38	Symptom 741 749	headache
T39	Symptom 751 765	visual changes
T40	TEST 774 785	All systems
T41	PROBLEM 899 918	Breast cancer (HCC)
T42	PROBLEM 924 937	Endometriosis
T43	PROBLEM 943 989	Malignant neoplasm of left female breast (HCC)
T44	PROBLEM 1005 1009	PONV
T45	PROBLEM 1011 1031	postoperative nausea
T46	PROBLEM 1036 1044	vomiting
T47	PROBLEM 1109 1149	Malignant neoplasm of female breast (HCC
T48	TREATMENT 1203 1210	surgery
T49	TREATMENT 1223 1255	Status post bilateral mastectomy
T50	TREATMENT 1271 1285	S/P mastectomy
T51	TREATMENT 1349 1356	surgery
T52	TREATMENT 1441 1448	surgery
T53	PROBLEM 1461 1477	Wound disruption
T54	TREATMENT 1554 1561	surgery
T55	PROBLEM 1574 1587	Breast cancer
T56	PROBLEM 1589 1599	left (HCC)
T57	PROBLEM 1615 1619	PONV
T58	PROBLEM 1621 1641	postoperative nausea
T59	PROBLEM 1646 1654	vomiting
T60	PROBLEM 1671 1716	Malignant neoplasm of left female breast (HCC
T61	PROBLEM 1733 1747	Clinical stage
T62	TEST 1797 1812	Screening mammo
T63	PROBLEM 1852 1883	1.8cm irregular spiculated mass
T64	PROBLEM 1889 1914	overlying skin retraction
T65	PROBLEM 1939 1970	1.3cm irregular spiculated mass
T66	PROBLEM 1999 2047	Small benign appearing oval circumscribed masses
T67	PROBLEM 2098 2132	Multiple oval circumscribed masses
T68	TEST 2166 2178	Bilateral US
T69	TEST 2233 2239	5cm FN
T70	PROBLEM 2241 2295	1.8 x 1.1 x 0.9cm irregular spiculated hypoechoic mass
T71	PROBLEM 2337 2380	0.8 x 0.9 x 1.3cm irregular spiculated mass
T72	PROBLEM 2401 2416	Few small cysts
T73	PROBLEM 2421 2445	left axillary adenopathy
T74	TEST 2460 2466	4cm FN
T75	PROBLEM 2468 2495	0.9 x 0.6 x 0.5cm oval mass
T76	PROBLEM 2501 2523	microlobulated margins
T77	PROBLEM 2586 2664	RIGHT inner retroareolar additional benign appearing oval circumscribed masses
T78	PROBLEM 2675 2680	cysts
T79	TEST 2730 2732	FN
T80	PROBLEM 2747 2750	IDC
T81	PROBLEM 2764 2767	LVI
T82	TEST 2795 2797	PR
T83	TEST 2839 2849	FISH  HER2
T84	PROBLEM 2903 2906	IDC
T85	PROBLEM 2920 2923	LVI
T86	TEST 2951 2953	PR
T87	TEST 2961 2966	Ki-67
T88	TEST 2976 2980	HER2
T89	PROBLEM 3000 3012	LCIS focally
T90	TEST 3032 3034	FN
T91	TEST 3039 3046	cm mass
T92	PROBLEM 3049 3068	Sclerosing adenosis
T93	PROBLEM 3083 3085	CA
T94	TEST 3122 3132	MRI breast
T95	PROBLEM 3135 3162	LEFT posterior lateral mass
T96	PROBLEM 3288 3308	abnormally thickened
T97	PROBLEM 3334 3359	abnormal skin enhancement
T98	PROBLEM 3361 3394	LEFT anterior-medial smaller mass
T99	PROBLEM 3422 3534	Highly suspicious lower outer (3:30-5:30) segmental nonmass enhancement inferior, medial and between both masses
T100	PROBLEM 3570 3603	Few small inner left breast cysts
T101	PROBLEM 3608 3627	axillary adenopathy
T102	PROBLEM 3647 3661	multiple cysts
T103	TEST 3747 3757	Mammaprint
T104	TEST 3776 3782	CT CAP
T105	PROBLEM 3786 3819	Enhancing mass in the left breast
T106	PROBLEM 3824 3852	axillary, hilar, mammary LAD
T107	PROBLEM 3858 3870	distant mets
T108	TEST 3883 3886	MRI
T109	PROBLEM 3930 3959	two adjacent irregular masses
T110	PROBLEM 3965 4014	spiculated margins in the lower outer left breast
T111	TEST 4046 4066	post gad axial image
T112	TREATMENT 4107 4120	a biopsy clip
T113	PROBLEM 4133 4142	each mass
T114	TEST 4144 4171	Signal intensity/time curve
T115	PROBLEM 4185 4236	rapid initial rise and washout enhancement kinetics
T116	PROBLEM 4267 4298	asymmetric non-mass enhancement
T117	PROBLEM 4323 4343	the two index masses
T118	PROBLEM 4360 4364	DCIS
T119	PROBLEM 4459 4508	a 5 mm oval mass in the outer central left breast
T120	TEST 4539 4559	post gad axial image
T121	TEST 4570 4597	Signal intensity/time curve
T122	PROBLEM 4611 4662	rapid initial rise and washout enhancement kinetics
T123	PROBLEM 4664 4673	This mass
T124	PROBLEM 4714 4730	the index masses
T125	PROBLEM 4763 4810	2 adjacent foci in the upper outer right breast
T126	TEST 4859 4879	post gad axial image
T127	TEST 4890 4917	Signal intensity/time curve
T128	PROBLEM 4931 4982	rapid initial rise and plateau enhancement kinetics
T129	TEST 5022 5042	post gad axial image
T130	TEST 5053 5080	Signal intensity/time curve
T131	PROBLEM 5094 5113	medium initial rise
T132	PROBLEM 5118 5149	persistent enhancement kinetics
T133	TREATMENT 5166 5218	a post biopsy clip in the outer central right breast
T134	TEST 5242 5248	biopsy
T136	RadPathResult 5328 5348	non-mass enhancement
T137	TEST 5364 5379	the biopsy clip
T138	TEST 5394 5414	post gad axial image
T139	PROBLEM 5452 5475	the sclerosing adenosis
T140	TREATMENT 5494 5503	tamoxifen
T141	TREATMENT 5523 5540	zoladex injection
T142	TREATMENT 5571 5580	tamoxifen
T143	TREATMENT 5584 5593	letrozole
T144	TREATMENT 5611 5620	letrozole
T145	TREATMENT 5640 5649	tamoxifen
T146	Symptom 5663 5673	depression
T147	TREATMENT 5686 5708	bilateral mastectomies
T148	TREATMENT 5761 5770	tamoxifen
T149	TREATMENT 5782 5794	OS/letrozole
T150	TREATMENT 5827 5835	letrozle
T151	TREATMENT 5839 5849	exemestane
T152	Symptom 5857 5864	anxiety
T153	Symptom 5869 5887	emotional lability
T154	MedicationName 5894 5901	zoladex
T155	ClinicalCondition 5928 5946	Polycystic ovaries
T156	PROBLEM 6004 6014	amenorrhea
T157	PROBLEM 6079 6093	increased pain
T158	TREATMENT 6099 6108	ovulation
T159	PROBLEM 6160 6174	Cyst of breast
T160	TEST 6235 6239	EXAM
T161	PROBLEM 6241 6260	2 left breast lumps
T162	TEST 6270 6293	self breast examination
T163	TEST 6324 6370	Unilateral LEFT digital diagnostic mammography
T164	PROBLEM 6406 6409	CAD
T165	TEST 6411 6441	limited left breast ultrasound
T166	TEST 6491 6517	3 views of the left breast
T167	PROBLEM 6586 6625	a large rounded benign-appearing nodule
T168	PROBLEM 6722 6745	dense breast parenchyma
T169	PROBLEM 6816 6829	a second lump
T170	PROBLEM 6852 6867	spiculated mass
T171	PROBLEM 6871 6895	suspicious calcification
T172	TEST 6912 6942	Limited left breast ultrasound
T173	PROBLEM 6953 6965	a large cyst
T174	PROBLEM 6977 7003	one thin partial septation
T175	PROBLEM 7110 7132	the 2 palpable nodules
T176	PROBLEM 7144 7163	a small simple cyst
T177	PROBLEM 7254 7280	the second palpable nodule
T178	PROBLEM 7286 7298	solid nodule
T179	PROBLEM 7328 7361	2 simple cysts in the left breast
T180	PROBLEM 7377 7403	the palpable abnormalities
T181	TREATMENT 7409 7424	Cyst aspiration
T182	PROBLEM 7428 7443	the larger cyst
T183	PROBLEM 7466 7470	pain
T184	PROBLEM 7488 7496	symptoms
T185	TEST 7505 7543	routine bilateral followup mammography
T186	PROBLEM 7644 7658	Mass of breast
T187	PROBLEM 7746 7761	EXTREMELY DENSE
T188	TEST 7791 7802	MAMMOGRAPHY
T189	PROBLEM 7825 7835	MALIGNANCY
T190	PROBLEM 7843 7858	INTERVAL CHANGE
T191	TEST 7866 7885	SCREENING MAMMOGRAM
T192	PROBLEM 7934 7963	a couple of lumps left breast
T193	Symptom 7969 7985	nipple discharge
T194	PROBLEM 7988 8015	Some discomfort left breast
T195	PROBLEM 8022 8031	Neck pain
T196	TEST 8127 8133	workup
T197	TEST 8148 8155	imaging
T198	PROBLEM 8192 8201	neck pain
T199	ProcedureName 8241 8243	PT
T200	TREATMENT 8314 8334	some muscle relaxers
T201	Symptom 8367 8375	Numbness
T202	PROBLEM 8380 8400	tingling in left arm
T203	PROBLEM 8437 8453	Her arm symptoms
T204	PROBLEM 8546 8562	Anxiety disorder
T205	TREATMENT 8580 8591	MEDICATIONS
T206	TREATMENT 8593 8623	Current Outpatient Medications
T207	TREATMENT 8626 8656	Medication Sig Dispense Refill
T208	TREATMENT 8661 8681	amoxicillin (AMOXIL)
T209	TREATMENT 8749 8784	amoxicillin-clavulanate (AUGMENTIN)
T210	TREATMENT 8824 8846	benzonatate (TESSALON)
T211	TREATMENT 8890 8915	buPROPion (WELLBUTRIN XL)
T212	TREATMENT 8964 8988	doxycycline (VIBRA-TABS)
T213	TREATMENT 9057 9078	exemestane (AROMASIN)
T214	TREATMENT 9144 9177	HYDROcodone-acetaminophen (NORCO)
T215	PROBLEM 9248 9252	PAIN
T216	TREATMENT 9266 9269	IBU
T217	TREATMENT 9338 9362	metroNIDAZOLE (METROGEL)
T218	TREATMENT 9417 9441	ondansetron (ZOFRAN-ODT)
T219	PROBLEM 9526 9532	NAUSEA
T220	PROBLEM 9533 9541	VOMITING
T221	TREATMENT 9582 9593	medications
T222	PROBLEM 9617 9639	ALLERGIES    Allergies
T223	TREATMENT 9660 9678	Allergen Reactions
T224	TREATMENT 9683 9694	Latex Hives
T225	PROBLEM 9715 9726	Anaphylaxis
T226	TREATMENT 9731 9748	Penicillins Hives
T227	TREATMENT 9753 9760	Codeine
T228	PROBLEM 9761 9767	Nausea
T229	TEST 9779 9792	PHYSICAL EXAM
T230	TEST 9794 9805	Vital signs
T231	TEST 9809 9815	Vitals
T232	TEST 9838 9840	BP
T233	TEST 9851 9856	Pulse
T234	TEST 9863 9867	Resp
T235	TEST 9874 9878	Temp
T236	TEST 9883 9884	C
T237	TEST 9896 9903	TempSrc
T238	TEST 9905 9920	Temporal   SpO2
T239	TEST 9929 9935	Weight
T240	TEST 9963 9969	Height
T241	PROBLEM 10080 10088	distress
T242	TEST 10184 10209	extraocular eye movements
T243	PROBLEM 10273 10280	lesions
T244	PROBLEM 10300 10322	significant adenopathy
T245	PROBLEM 10340 10389	suspicious cervical, SC, axillary lymphadenopathy
T246	TEST 10408 10420	auscultation
T247	PROBLEM 10425 10432	wheezes
T248	PROBLEM 10434 10439	rales
T249	PROBLEM 10443 10450	rhonchi
T250	PROBLEM 10528 10535	murmurs
T251	PROBLEM 10537 10541	rubs
T252	PROBLEM 10543 10549	clicks
T253	PROBLEM 10553 10560	gallops
T254	PROBLEM 10578 10587	nontender
T255	PROBLEM 10589 10601	nondistended
T256	PROBLEM 10606 10612	masses
T257	PROBLEM 10616 10628	organomegaly
T258	TREATMENT 10643 10679	bilateral mastectomies with implants
T259	PROBLEM 10684 10701	suspicious masses
T260	PROBLEM 10703 10710	nodules
T261	PROBLEM 10712 10718	rashes
T262	TEST 10733 10742	Back exam
T263	PROBLEM 10770 10780	tenderness
T264	PROBLEM 10782 10796	palpable spasm
T265	PROBLEM 10800 10804	pain
T266	PROBLEM 10866 10880	focal findings
T267	PROBLEM 10884 10901	movement disorder
T268	PROBLEM 10930 10946	joint tenderness
T269	PROBLEM 10948 10957	deformity
T270	PROBLEM 10961 10969	swelling
T271	TEST 10985 11002	peripheral pulses
T272	PROBLEM 11014 11025	pedal edema
T273	PROBLEM 11030 11038	clubbing
T274	PROBLEM 11042 11050	cyanosis
T275	PROBLEM 11092 11098	rashes
T276	PROBLEM 11103 11126	suspicious skin lesions
T277	PROBLEM 11236 11254	left breast cancer
T278	PROBLEM 11256 11298	mammaprint low risk IDC of the left breast
T279	TREATMENT 11313 11322	tamoxifen
T280	TREATMENT 11328 11350	bilateral mastectomies
T281	TREATMENT 11352 11374	s/p adjuvant tamoxifen
T282	TREATMENT 11412 11424	OS/letrozole
T283	TREATMENT 11460 11469	letrozole
T284	TREATMENT 11473 11483	exemestane
T285	PROBLEM 11508 11515	anxiety
T286	PROBLEM 11520 11538	emotional lability
T287	ClinicalCondition 11556 11562	Cancer
T288	TEST 11572 11576	exam
T289	TREATMENT 11588 11598	exemestane
T290	TEST 11673 11697	checking estradiol level
T291	PROBLEM 11708 11727	ovarian suppression
T292	Radiology 11770 11779	DEXA scan
T293	Symptom 11808 11818	osteopenia
T294	TREATMENT 11839 11853	bisphosphonate
T295	TEST 11864 11892	adjuvant bisphosphonate data
T296	PROBLEM 11901 11921	reduced distant mets
T297	TREATMENT 11949 11969	postmenopausal women
T298	TREATMENT 11974 11992	bisphosphonate use
T299	ProcedureName 12016 12019	BSO
T300	PROBLEM 12106 12108	AI
T301	TEST 12121 12135	q6months exams
T302	Radiology 12140 12147	imaging
T303	TREATMENT 12154 12176	bilateral mastectomies
T304	Symptom 12183 12193	Depression
T305	PROBLEM 12194 12201	Anxiety
T306	TREATMENT 12245 12260	ongoing support
T307	PROBLEM 12320 12345	new or worsening symptoms
T308	TREATMENT 12415 12426	medications
T309	TREATMENT 12587 12605	the treatment plan
T310	PROBLEM 12607 12615	symptoms
T311	TREATMENT 12620 12639	therapeutic options
T312	Age 31 33	49
T313	BiomarkerName 51 53	ER
A2	HistoryVal T313 history
A3	EpisodeDescription T313 FirstOccurrence
T314	BiomarkerName 55 57	PR
A4	HistoryVal T314 history
A5	EpisodeDescription T314 FirstOccurrence
T315	BiomarkerName 59 63	HER2
A6	HistoryVal T315 history
A7	EpisodeDescription T315 FirstOccurrence
T316	BiomarkerName 11222 11224	ER
A8	HistoryVal T316 history
A9	EpisodeDescription T316 FirstOccurrence
T317	BiomarkerName 11226 11228	PR
A10	HistoryVal T317 history
A11	EpisodeDescription T317 FirstOccurrence
T318	BiomarkerName 11230 11234	HER2
A12	HistoryVal T318 history
A13	EpisodeDescription T318 FirstOccurrence
T319	BiomarkerResult 11224 11225	+
A14	HistoryVal T319 history
A15	EpisodeDescription T319 FirstOccurrence
A16	BiomarkerResultVal T319 Positive
T320	BiomarkerResult 11228 11229	-
A17	HistoryVal T320 history
A18	BiomarkerResultVal T320 Negative
T321	BiomarkerResult 11234 11235	-
A19	HistoryVal T321 history
A20	BiomarkerResultVal T321 Negative
T322	BiomarkerResult 57 58	-
A21	HistoryVal T322 history
A22	BiomarkerResultVal T322 Negative
T323	BiomarkerResult 63 64	-
A23	HistoryVal T323 history
A24	BiomarkerResultVal T323 Negative
T324	BiomarkerResult 53 54	+
A25	HistoryVal T324 history
A26	BiomarkerResultVal T324 Positive
R1	BiomarkerRel Arg1:T313 Arg2:T324	
R2	BiomarkerRel Arg1:T314 Arg2:T322	
R3	BiomarkerRel Arg1:T315 Arg2:T323	
T325	ClinicalCondition 77 83	cancer
A27	ChronicVal T325 chronic
A28	ContinuityVal T325 stable
T326	ClinicalCondition 906 918	cancer (HCC)
A29	ChronicVal T326 chronic
A30	ContinuityVal T326 stable
T327	ClinicalCondition 924 937	Endometriosis
A31	ChronicVal T327 chronic
A32	ContinuityVal T327 stable
T328	ClinicalCondition 943 989	Malignant neoplasm of left female breast (HCC)
A33	ChronicVal T328 chronic
A34	ContinuityVal T328 stable
T329	ClinicalCondition 1109 1150	Malignant neoplasm of female breast (HCC)
A35	ChronicVal T329 chronic
A36	ContinuityVal T329 stable
T330	ClinicalCondition 1581 1587	cancer
A37	ChronicVal T330 chronic
A38	ContinuityVal T330 stable
T331	ClinicalCondition 1671 1717	Malignant neoplasm of left female breast (HCC)
A39	ChronicVal T331 chronic
A40	ContinuityVal T331 stable
T332	Laterality 65 69	left
T333	Laterality 116 120	left
T334	Laterality 142 151	bilateral
T335	Site 1235 1244	bilateral
T336	Site 1287 1296	bilateral
T337	Laterality 1589 1593	left
T338	GenomicTest 85 95	mammaprint
A41	IntentVal T338 staging
A42	GenomicTestType T338 GeneExpression
T339	GenomicTestResult 96 104	low risk
A43	GenomicTestType T339 GeneExpression
T340	Histology 105 108	IDC
A44	HistoryVal T340 history
A45	EpisodeDescription T340 FirstOccurrence
T341	Site 121 127	breast
R5	LateralityOfSite Arg1:T333 Arg2:T341	
R6	SiteOf Arg1:T341 Arg2:T340	
T342	TreatmentType 132 136	NAHT
A46	TreatmentContinuityVal T342 finished
A47	TreatmentTypeVal T342 neoadjuvant
A48	TreatmentIntentVal T342 curative
T343	ProcedureName 152 164	mastectomies
A49	IntentVal T343 treatment-curative
A50	TreatmentTypeVal T343 local
A51	TreatmentCategory T343 Others
A52	IsTumorRemaining T343 unclear
T344	MedicationName 179 188	tamoxifen
A53	TreatmentContinuityVal T344 finished
A54	TreatmentTypeVal T344 adjuvant
A55	TreatmentIntentVal T344 curative
A56	TreatmentCategory T344 AntiNeoPlastics
T345	TreatmentType 234 239	OS/AI
A57	TreatmentContinuityVal T345 continuing
A58	TreatmentTypeVal T345 adjuvant
A59	TreatmentIntentVal T345 curative
T346	Datetime 243 256	November 2018
R7	BeginsOnOrAt Arg1:T346 Arg2:T345	
T347	MedicationName 272 281	letrozole
A60	TreatmentContinuityVal T347 discontinued_early
A61	TreatmentTypeVal T347 adjuvant
A62	TreatmentIntentVal T347 curative
A63	TreatmentCategory T347 AntiNeoPlastics
T348	MedicationName 285 295	exemestane
A64	TreatmentContinuityVal T348 continuing
A65	TreatmentTypeVal T348 adjuvant
A66	TreatmentIntentVal T348 curative
A67	TreatmentCategory T348 AntiNeoPlastics
T349	Datetime 296 309	December 2018
R8	BeginsOnOrAt Arg1:T348 Arg2:T349	
R9	EndsOnOrAt Arg1:T347 Arg2:T349	
T350	Symptom 317 324	anxiety
A68	IsPresentOnFirstCancerDiagnosis T350 no
A69	IsCausedByDiagnosedCancer T350 no
A70	ChronicVal T350 non-chronic
A71	ContinuityVal T350 stopped
T351	Symptom 329 347	emotional lability
A72	IsPresentOnFirstCancerDiagnosis T351 no
A73	IsCausedByDiagnosedCancer T351 no
A74	ChronicVal T351 non-chronic
A75	ContinuityVal T351 stopped
R10	TreatmentDiscontinuedBecauseOf Therapy:T347 Reason:T350	
R11	TreatmentDiscontinuedBecauseOf Therapy:T347 Reason:T351	
R12	ConditionOrTreatmentCausesProblem Treatment:T347 Prob:T350	
R13	ConditionOrTreatmentCausesProblem Treatment:T347 Prob:T351	
T352	MedicationName 382 391	letrozole
A76	TreatmentContinuityVal T352 discontinued_early
A77	TreatmentTypeVal T352 adjuvant
A78	TreatmentIntentVal T352 curative
A79	TreatmentCategory T352 AntiNeoPlastics
T353	MedicationName 431 441	exemestane
A80	TreatmentContinuityVal T353 continuing
A81	TreatmentTypeVal T353 adjuvant
A82	TreatmentIntentVal T353 curative
A83	TreatmentCategory T353 AntiNeoPlastics
T354	MedicationName 497 507	exemestane
A84	TreatmentContinuityVal T354 continuing
A85	TreatmentTypeVal T354 adjuvant
A86	TreatmentIntentVal T354 curative
A87	TreatmentCategory T354 AntiNeoPlastics
T355	PROBLEM 461 468	anxiety
T356	PROBLEM 473 484	mood swings
T357	Duration 403 414	12.5 months
R14	HappensAtOnDuring Arg1:T352 Arg2:T357	
T25	Symptom 461 468	anxiety
A89	IsPresentOnFirstCancerDiagnosis T25 no
A90	IsCausedByDiagnosedCancer T25 no
A91	ChronicVal T25 non-chronic
A92	ContinuityVal T25 stopped
T26	Symptom 473 484	mood swings
A93	IsPresentOnFirstCancerDiagnosis T26 no
A94	IsCausedByDiagnosedCancer T26 no
A95	ChronicVal T26 non-chronic
A96	ContinuityVal T26 stopped
R15	ConditionOrTreatmentCausesProblem Treatment:T352 Prob:T25	
R16	TreatmentDiscontinuedBecauseOf Therapy:T352 Reason:T25	
R17	TreatmentDiscontinuedBecauseOf Therapy:T352 Reason:T26	
R18	ConditionOrTreatmentCausesProblem Treatment:T352 Prob:T26	
T358	Symptom 518 538	+minimal joint aches
A97	IsPresentOnFirstCancerDiagnosis T358 unclear
A98	IsCausedByDiagnosedCancer T358 no
A99	ContinuityVal T358 unclear
T359	Symptom 540 557	+mild hot flashes
A100	IsPresentOnFirstCancerDiagnosis T359 unclear
A101	IsCausedByDiagnosedCancer T359 no
A102	ContinuityVal T359 unclear
T360	Symptom 562 570	insomnia
A103	IsPresentOnFirstCancerDiagnosis T360 unclear
A104	IsCausedByDiagnosedCancer T360 no
A105	ContinuityVal T360 unclear
T361	Symptom 572 582	+bone pain
A106	IsPresentOnFirstCancerDiagnosis T361 unclear
A107	IsCausedByDiagnosedCancer T361 no
A108	ContinuityVal T361 unclear
T362	Symptom 584 600	+vaginal dryness
A109	IsPresentOnFirstCancerDiagnosis T362 unclear
A110	IsCausedByDiagnosedCancer T362 no
A111	ContinuityVal T362 unclear
T363	PhysicalActivity 669 677	exercise
A112	IsStoppedOrContinuing T363 continuing
A113	ExperiencerVal T363 patient
T364	Symptom 703 712	bone pain
A114	NegationModalityVal T364 negated
T365	Symptom 714 717	sob
A115	NegationModalityVal T365 negated
T366	Symptom 719 724	cough
A116	NegationModalityVal T366 negated
T367	Symptom 726 734	abd pain
A117	NegationModalityVal T367 negated
T368	Symptom 736 739	n/v
A118	NegationModalityVal T368 negated
A119	NegationModalityVal T38 negated
A120	NegationModalityVal T39 negated
T369	Datetime 990 1000	01/10/2017
R19	HappensAtOnDuring Arg1:T369 Arg2:T328	
T370	Symptom 1005 1045	PONV (postoperative nausea and vomiting)
A121	IsPresentOnFirstCancerDiagnosis T370 no
A122	IsCausedByDiagnosedCancer T370 no
A123	ChronicVal T370 non-chronic
A124	ContinuityVal T370 stopped
T371	Symptom 1615 1655	PONV (postoperative nausea and vomiting)
A125	IsPresentOnFirstCancerDiagnosis T371 no
A126	IsCausedByDiagnosedCancer T371 no
A127	ChronicVal T371 non-chronic
A128	ContinuityVal T371 stopped
T372	Datetime 1151 1161	11/12/2017
R20	BeginsOnOrAt Arg1:T372 Arg2:T329	
T373	Datetime 1256 1266	07/18/2017
T374	ProcedureName 1245 1255	mastectomy
A129	IntentVal T374 treatment-curative
A130	TreatmentTypeVal T374 local
A131	TreatmentCategory T374 Others
A132	IsTumorRemaining T374 no
R21	HappensAtOnDuring Arg1:T373 Arg2:T374	
T375	ProcedureName 1275 1285	mastectomy
A133	IntentVal T375 treatment-curative
A134	TreatmentTypeVal T375 local
A135	TreatmentCategory T375 Others
A136	IsTumorRemaining T375 no
T376	Datetime 1297 1307	05/27/2017
R22	HappensAtOnDuring Arg1:T376 Arg2:T375	
T377	Datetime 1389 1399	05/27/2017
T378	Datetime 1502 1512	05/27/2017
T379	ClinicalCondition 1461 1477	Wound disruption
A137	ChronicVal T379 non-chronic
A138	ContinuityVal T379 stopped
A139	ExperiencerVal T379 patient
T380	Site 1488 1492	skin
R23	HappensAtOnDuring Arg1:T378 Arg2:T379	
R24	SiteOf Arg1:T380 Arg2:T379	
T381	Datetime 1600 1610	04/09/2017
R25	HappensAtOnDuring Arg1:T381 Arg2:T330	
T382	Datetime 1656 1666	03/27/2017
T383	Datetime 1718 1728	01/10/2017
T384	Datetime 1787 1795	12/05/16
R26	HappensAtOnDuring Arg1:T382 Arg2:T371	
R27	HappensAtOnDuring Arg1:T383 Arg2:T331	
T385	Stage 1748 1751	2-3
A140	ExperiencerVal T385 patient
A141	HistoryVal T385 history
A142	EpisodeDescription T385 FirstOccurrence
T386	BiomarkerName 1752 1754	HR
A143	ExperiencerVal T386 patient
A144	HistoryVal T386 history
A145	EpisodeDescription T386 FirstOccurrence
T387	BiomarkerName 1756 1760	HER2
A146	ExperiencerVal T387 patient
A147	HistoryVal T387 history
A148	EpisodeDescription T387 FirstOccurrence
T388	BiomarkerResult 1754 1755	+
A149	HistoryVal T388 history
A150	EpisodeDescription T388 FirstOccurrence
A151	BiomarkerResultVal T388 Positive
R28	BiomarkerRel Arg1:T388 Arg2:T386	
T389	BiomarkerResult 1761 1769	negative
A152	HistoryVal T389 history
A153	EpisodeDescription T389 FirstOccurrence
A154	BiomarkerResultVal T389 Negative
R29	BiomarkerRel Arg1:T387 Arg2:T389	
T390	Histology 1770 1773	IDC
A155	ExperiencerVal T390 patient
A156	HistoryVal T390 history
A157	EpisodeDescription T390 FirstOccurrence
T391	TreatmentType 1777 1781	NAHT
A158	TreatmentContinuityVal T391 finished
A159	TreatmentTypeVal T391 neoadjuvant
A160	TreatmentIntentVal T391 curative
R30	HappensAtOnDuring Arg1:T383 Arg2:T391	
T392	Radiology 1807 1812	mammo
A161	ExperiencerVal T392 patient
A162	IntentVal T392 screening
R31	HappensAtOnDuring Arg1:T392 Arg2:T384	
T393	RadPathResult 1815 1830	Extremely dense
A163	RadPathResultVal T393 Unclear
R32	ResultOfTest Desc:T393 Test:T392	
T394	Laterality 1832 1836	LEFT
T395	Laterality 1917 1921	LEFT
T396	Laterality 1972 1976	LEFT
T397	Laterality 2072 2077	RIGHT
T398	Laterality 2316 2320	LEFT
T399	Laterality 2447 2452	RIGHT
T400	Laterality 2586 2591	RIGHT
T401	Laterality 2869 2873	LEFT
T402	Laterality 3015 3020	RIGHT
T403	Laterality 3135 3139	LEFT
T404	Laterality 3361 3365	LEFT
T405	Laterality 3629 3634	RIGHT
T406	Laterality 3888 3892	LEFT
T407	Laterality 3808 3812	left
T408	Laterality 4003 4007	left
T409	Laterality 4497 4501	left
T410	Laterality 4735 4740	RIGHT
T411	Laterality 4798 4803	right
T414	Site 1979 1998	inner retroareolar:
T416	RadPathResult 1858 1883	irregular spiculated mass
A165	RadPathResultVal T416 InitialCancerDiagnosis
T417	Site 2078 2096	inner retroareolar
T418	RadPathResult 2098 2132	Multiple oval circumscribed masses
A166	RadPathResultVal T418 NoDisease
T419	RadPathResult 1999 2047	Small benign appearing oval circumscribed masses
A167	RadPathResultVal T419 NoDisease
T412	Site 1837 1850	3:30, 5 cm FN
T413	Site 1922 1937	3:30, 2.5 cm FN
T415	Site 2321 2335	3:30, 2.5cm FN
T421	Site 2453 2466	11:00, 4cm FN
T422	Size 1852 1857	1.8cm
A164	HistoryVal T422 new
A168	EpisodeDescription T422 FirstOccurrence
T423	Size 1939 1944	1.3cm
A169	HistoryVal T423 new
A170	EpisodeDescription T423 FirstOccurrence
R33	ResultOfTest Desc:T416 Test:T392	
T424	RadPathResult 1945 1970	irregular spiculated mass
A171	RadPathResultVal T424 InitialCancerDiagnosis
R34	ResultOfTest Desc:T424 Test:T392	
R35	ResultOfTest Desc:T419 Test:T392	
T425	Radiology 2176 2178	US
A172	IntentVal T425 diagnosis
T426	Datetime 2156 2164	12/05/16
R36	HappensAtOnDuring Arg1:T426 Arg2:T425	
R37	ResultOfTest Desc:T418 Test:T392	
R38	SiteOf Arg1:T414 Arg2:T419	
R39	SiteOf Arg1:T417 Arg2:T418	
R40	LateralityOfSite Arg1:T397 Arg2:T417	
R41	LateralityOfSite Arg1:T396 Arg2:T414	
R42	SiteOf Arg1:T413 Arg2:T424	
R43	SiteOf Arg1:T413 Arg2:T423	
R44	LateralityOfSite Arg1:T395 Arg2:T413	
R45	LateralityOfSite Arg1:T394 Arg2:T412	
R46	SiteOf Arg1:T412 Arg2:T422	
R47	SiteOf Arg1:T412 Arg2:T416	
T420	Site 2227 2239	3:30, 5cm FN
T427	Site 2720 2732	3:30, 5cm FN
T428	Laterality 2222 2226	LEFT
T429	Size 2241 2258	1.8 x 1.1 x 0.9cm
A173	HistoryVal T429 new
A174	EpisodeDescription T429 FirstOccurrence
R48	SiteOf Arg1:T420 Arg2:T429	
R49	LateralityOfSite Arg1:T428 Arg2:T420	
T430	RadPathResult 2259 2295	irregular spiculated hypoechoic mass
A175	RadPathResultVal T430 InitialCancerDiagnosis
R50	ResultOfTest Desc:T430 Test:T425	
R51	SiteOf Arg1:T420 Arg2:T430	
T431	Size 2337 2354	0.8 x 0.9 x 1.3cm
A176	EpisodeDescription T431 FirstOccurrence
T432	Size 2468 2485	0.9 x 0.6 x 0.5cm
A177	EpisodeDescription T432 FirstOccurrence
T433	Size 2890 2895	1.3cm
A178	EpisodeDescription T433 FirstOccurrence
T434	Size 3036 3041	0.9cm
A179	EpisodeDescription T434 FirstOccurrence
T435	LymphNodeInvolvement 2435 2445	adenopathy
A180	NegationModalityVal T435 negated
A181	HistoryVal T435 new
A182	EpisodeDescription T435 FirstOccurrence
T436	Site 2426 2434	axillary
T437	Laterality 2421 2425	left
R52	LateralityOfSite Arg1:T437 Arg2:T436	
R53	SiteOf Arg1:T436 Arg2:T435	
R54	TestOrProcedureReveals Test:T425 Desc:T435	
T438	RadPathResult 2486 2523	oval mass with microlobulated margins
A183	RadPathResultVal T438 NoDisease
T439	RadPathResult 2355 2380	irregular spiculated mass
A184	RadPathResultVal T439 InitialCancerDiagnosis
R55	SiteOf Arg1:T415 Arg2:T431	
R56	SiteOf Arg1:T415 Arg2:T439	
R57	LateralityOfSite Arg1:T398 Arg2:T415	
R58	ResultOfTest Desc:T439 Test:T425	
T440	RadPathResult 2401 2416	Few small cysts
A185	RadPathResultVal T440 NoDisease
R59	ResultOfTest Desc:T440 Test:T425	
R60	LateralityOfSite Arg1:T399 Arg2:T421	
R61	SiteOf Arg1:T421 Arg2:T432	
R62	SiteOf Arg1:T421 Arg2:T438	
T441	Site 2592 2610	inner retroareolar
T442	RadPathResult 2622 2664	benign appearing oval circumscribed masses
A186	RadPathResultVal T442 NoDisease
R63	SiteOf Arg1:T441 Arg2:T442	
T443	RadPathResult 2675 2680	cysts
A187	RadPathResultVal T443 NoDisease
R64	SiteOf Arg1:T441 Arg2:T443	
R65	LateralityOfSite Arg1:T400 Arg2:T441	
R66	ResultOfTest Desc:T442 Test:T425	
R67	ResultOfTest Desc:T443 Test:T425	
T444	Laterality 2715 2719	LEFT
T445	Size 2734 2739	1.8cm
A188	EpisodeDescription T445 FirstOccurrence
T446	Histology 2747 2750	IDC
A189	EpisodeDescription T446 FirstOccurrence
T447	Grade 2758 2759	2
A190	EpisodeDescription T447 FirstOccurrence
T448	LocalInvasion 2764 2767	LVI
A191	EpisodeDescription T448 FirstOccurrence
A192	NegationModalityVal T448 negated
T449	BiomarkerName 2784 2786	ER
A193	HistoryVal T449 new
A194	EpisodeDescription T449 FirstOccurrence
T450	BiomarkerName 2795 2797	PR
A195	HistoryVal T450 new
A196	EpisodeDescription T450 FirstOccurrence
T451	BiomarkerName 2808 2813	Ki-67
A197	HistoryVal T451 new
A198	EpisodeDescription T451 FirstOccurrence
T452	BiomarkerName 2821 2826	Her-2
A199	HistoryVal T452 new
A200	EpisodeDescription T452 FirstOccurrence
T453	BiomarkerName 2845 2849	HER2
A201	HistoryVal T453 new
A202	EpisodeDescription T453 FirstOccurrence
T454	BiomarkerName 2940 2942	ER
A203	HistoryVal T454 new
A204	EpisodeDescription T454 FirstOccurrence
T455	BiomarkerName 2951 2953	PR
A205	HistoryVal T455 new
A206	EpisodeDescription T455 FirstOccurrence
T456	BiomarkerName 2961 2966	Ki-67
A207	HistoryVal T456 new
A208	EpisodeDescription T456 FirstOccurrence
T457	BiomarkerName 2976 2980	HER2
A209	HistoryVal T457 new
A210	EpisodeDescription T457 FirstOccurrence
T458	BiomarkerResult 2787 2793	61-70%
A211	EpisodeDescription T458 FirstOccurrence
A212	BiomarkerResultVal T458 Positive
T459	BiomarkerResult 2798 2806	negative
A213	EpisodeDescription T459 FirstOccurrence
A214	BiomarkerResultVal T459 Negative
T460	BiomarkerResult 2813 2819	15-20%
A215	EpisodeDescription T460 FirstOccurrence
A216	BiomarkerResultVal T460 Unclear
T461	BiomarkerResult 2827 2835	negative
A217	EpisodeDescription T461 FirstOccurrence
A218	BiomarkerResultVal T461 Negative
T462	BiomarkerResult 2850 2858	negative
A219	EpisodeDescription T462 FirstOccurrence
A220	BiomarkerResultVal T462 Negative
T463	BiomarkerResult 2943 2949	41-50%
A221	EpisodeDescription T463 FirstOccurrence
A222	BiomarkerResultVal T463 Positive
T464	BiomarkerResult 2954 2959	1-10%
A223	EpisodeDescription T464 FirstOccurrence
A224	BiomarkerResultVal T464 LowPositive
T465	BiomarkerResult 2967 2973	30-40%
A225	EpisodeDescription T465 FirstOccurrence
A226	BiomarkerResultVal T465 Unclear
T466	BiomarkerResult 2981 2989	negative
A227	EpisodeDescription T466 FirstOccurrence
A228	BiomarkerResultVal T466 Negative
T467	LocalInvasion 2920 2923	LVI
A229	NegationModalityVal T467 negated
R68	BiomarkerRel Arg1:T449 Arg2:T458	
R69	BiomarkerRel Arg1:T450 Arg2:T459	
R70	BiomarkerRel Arg1:T451 Arg2:T460	
R71	BiomarkerRel Arg1:T452 Arg2:T461	
R72	BiomarkerRel Arg1:T453 Arg2:T462	
T468	Pathology 2839 2843	FISH
A230	IntentVal T468 diagnosis
R73	TestOrProcedureReveals Test:T468 Desc:T452	
T469	Pathology 2862 2866	FISH
A231	IntentVal T469 diagnosis
R74	TestOrProcedureReveals Test:T469 Desc:T453	
T470	Site 2874 2888	3:30, 2.5cm FN
R75	LateralityOfSite Arg1:T401 Arg2:T470	
R76	SiteOf Arg1:T470 Arg2:T433	
T471	Histology 2903 2906	IDC
A232	HistoryVal T471 new
A233	EpisodeDescription T471 FirstOccurrence
R77	SiteOf Arg1:T470 Arg2:T471	
R78	BiomarkerRel Arg1:T454 Arg2:T463	
R79	BiomarkerRel Arg1:T455 Arg2:T464	
R80	BiomarkerRel Arg1:T456 Arg2:T465	
R81	BiomarkerRel Arg1:T457 Arg2:T466	
T472	Pathology 2993 2997	FISH
A234	IntentVal T472 diagnosis
R82	TestOrProcedureReveals Test:T472 Desc:T457	
T473	Histology 2999 3004	+LCIS
A235	EpisodeDescription T473 FirstOccurrence
T474	Site 3021 3034	11:00. 4cm FN
R83	LateralityOfSite Arg1:T402 Arg2:T474	
R84	SiteOf Arg1:T474 Arg2:T434	
T475	RadPathResult 3049 3068	Sclerosing adenosis
A236	RadPathResultVal T475 NoDisease
T476	Datetime 3112 3120	12/22/16
T477	Radiology 3122 3125	MRI
A237	IntentVal T477 diagnosis
T478	Site 3126 3132	breast
R85	LateralityOfSite Arg1:T403 Arg2:T478	
R86	SiteOf Arg1:T478 Arg2:T477	
R87	HappensAtOnDuring Arg1:T476 Arg2:T477	
T479	Site 3140 3157	posterior lateral
T480	Site 3366 3381	anterior-medial
T481	Site 3591 3597	breast
T482	Site 3608 3616	axillary
T483	Site 3635 3641	breast
T486	Site 3813 3819	breast
T487	Site 3824 3832	axillary
T488	Site 3834 3839	hilar
T489	Site 3841 3848	mammary
T490	Site 3893 3899	Breast
T491	Site 4008 4014	breast
T492	Site 4016 4031	posterior depth
T493	Site 3991 4002	lower outer
T494	Site 4502 4508	breast
T495	Site 4483 4496	outer central
T496	Site 4510 4524	anterior depth
T497	Site 4741 4747	Breast
T498	Site 4804 4826	breast, anterior depth
T499	Site 4786 4797	upper outer
T500	Site 5212 5218	breast
T501	Site 5192 5205	outer central
T502	Laterality 3586 3590	left
T503	Laterality 5206 5211	right
R88	LateralityOfSite Arg1:T405 Arg2:T483	
T504	RadPathResult 3647 3661	multiple cysts
A238	RadPathResultVal T504 NoDisease
T484	Site 3691 3703	outer breast
T505	Site 3708 3733	3.lcm in the inner breast
R89	LateralityOfSite Arg1:T502 Arg2:T481	
T485	Size 3172 3189	2.4 x 2.5 x 2.9cm
A239	HistoryVal T485 new
A240	EpisodeDescription T485 FirstOccurrence
R90	SiteOf Arg1:T479 Arg2:T485	
R91	TestOrProcedureReveals Test:T477 Desc:T485	
T506	RadPathResult 3158 3162	mass
A241	RadPathResultVal T506 InitialCancerDiagnosis
R92	ResultOfTest Arg1:T506 Reason:T477	
T507	Site 3250 3278	within 2mm of overlying skin
T508	RadPathResult 3382 3394	smaller mass
A242	RadPathResultVal T508 InitialCancerDiagnosis
T509	Size 3404 3420	1.6 x 1.3x 1.5cm
A243	HistoryVal T509 new
A244	EpisodeDescription T509 FirstOccurrence
R93	LateralityOfSite Arg1:T404 Arg2:T480	
R94	SiteOf Arg1:T480 Arg2:T508	
R95	SiteOf Arg1:T480 Arg2:T509	
R97	ResultOfTest Desc:T508 Test:T477	
R96	ResultOfTest Desc:T506 Test:T477	
T510	Site 3440 3463	lower outer (3:30-5:30)
T511	RadPathResult 3464 3493	segmental nonmass enhancement
A245	RadPathResultVal T511 Unclear
R98	SiteOf Arg1:T510 Arg2:T511	
R99	ResultOfTest Desc:T511 Test:T477	
T512	RadPathResult 3598 3603	cysts
A246	RadPathResultVal T512 NoDisease
R100	ResultOfTest Desc:T512 Test:T477	
T513	LymphNodeInvolvement 3617 3627	adenopathy
A247	NegationModalityVal T513 negated
A248	HistoryVal T513 new
A249	EpisodeDescription T513 FirstOccurrence
R101	SiteOf Arg1:T482 Arg2:T513	
R102	TestOrProcedureReveals Test:T477 Desc:T513	
R103	SiteOf Arg1:T483 Arg2:T504	
R104	ResultOfTest Desc:T504 Test:T477	
R105	SiteOf Arg1:T484 Arg2:T504	
R106	SiteOf Arg1:T505 Arg2:T504	
T514	Datetime 3737 3745	01/06/17
T515	GenomicTest 3747 3757	Mammaprint
A250	IntentVal T515 staging
A251	GenomicTestType T515 GeneExpression
T516	GenomicTestResult 3760 3763	low
A252	GenomicTestType T516 GeneExpression
R107	ResultOfTest Desc:T516 Test:T515	
R108	HappensAtOnDuring Arg1:T514 Arg2:T515	
T517	Datetime 3766 3774	01/08/17
T518	Radiology 3776 3782	CT CAP
A253	IntentVal T518 staging
R109	HappensAtOnDuring Arg1:T517 Arg2:T518	
T519	RadPathResult 3796 3800	mass
A254	RadPathResultVal T519 InitialCancerDiagnosis
R110	ResultOfTest Desc:T519 Test:T518	
R111	LateralityOfSite Arg1:T407 Arg2:T486	
R112	LateralityOfSite Arg1:T407 Arg2:T487	
R113	LateralityOfSite Arg1:T407 Arg2:T488	
R114	LateralityOfSite Arg1:T407 Arg2:T489	
T520	LymphNodeInvolvement 3849 3852	LAD
A255	NegationModalityVal T520 negated
A256	HistoryVal T520 new
A257	EpisodeDescription T520 FirstOccurrence
R115	TestOrProcedureReveals Test:T518 Desc:T520	
T521	Metastasis 3858 3870	distant mets
A258	NegationModalityVal T521 negated
A259	EpisodeDescription T521 FirstOccurrence
R116	TestOrProcedureReveals Test:T518 Desc:T521	
T522	Datetime 3873 3881	01/10/17
T523	Radiology 3883 3886	MRI
A260	IntentVal T523 staging
R117	HappensAtOnDuring Arg1:T522 Arg2:T523	
R118	LateralityOfSite Arg1:T406 Arg2:T490	
T524	RadPathResult 3943 3959	irregular masses
A261	RadPathResultVal T524 Unclear
R119	LateralityOfSite Arg1:T408 Arg2:T491	
R120	LateralityOfSite Arg1:T408 Arg2:T493	
R121	SiteOf Arg1:T491 Arg2:T524	
R122	SiteOf Arg1:T493 Arg2:T524	
R123	LateralityOfSite Arg1:T408 Arg2:T492	
R124	SiteOf Arg1:T492 Arg2:T524	
T525	RadPathResult 4267 4298	asymmetric non-mass enhancement
A262	RadPathResultVal T525 Unclear
R125	ResultOfTest Desc:T524 Test:T523	
T526	Histology 4360 4364	DCIS
A263	NegationModalityVal T526 uncertain_in_present
R126	ResultOfTest Desc:T525 Test:T523	
T527	RadPathResult 4466 4475	oval mass
A264	RadPathResultVal T527 Unclear
R127	LateralityOfSite Arg1:T409 Arg2:T495	
R128	LateralityOfSite Arg1:T409 Arg2:T494	
R129	LateralityOfSite Arg1:T409 Arg2:T496	
R130	SiteOf Arg1:T495 Arg2:T527	
R131	SiteOf Arg1:T494 Arg2:T527	
R132	SiteOf Arg1:T496 Arg2:T527	
R133	ResultOfTest Desc:T527 Test:T523	
T528	Site 4691 4730	2 cm anterosuperior to the index masses
R134	SiteOf Arg1:T528 Arg2:T527	
R135	LateralityOfSite Arg1:T410 Arg2:T497	
R136	LateralityOfSite Arg1:T411 Arg2:T499	
R137	LateralityOfSite Arg1:T411 Arg2:T498	
T529	RadPathResult 4774 4778	foci
A265	RadPathResultVal T529 Unclear
R138	SiteOf Arg1:T499 Arg2:T529	
R139	SiteOf Arg1:T498 Arg2:T529	
R140	SiteOf Arg1:T497 Arg2:T529	
R141	ResultOfTest Desc:T529 Test:T523	
R142	LateralityOfSite Arg1:T503 Arg2:T501	
R143	LateralityOfSite Arg1:T503 Arg2:T500	
A266	RadPathResultVal T136 NoDisease
T135	Site 5354 5379	medial to the biopsy clip
R144	SiteOf Arg1:T135 Arg2:T136	
R145	ResultOfTest Desc:T136 Test:T523	
T530	Datetime 5478 5486	01/11/17
T531	Datetime 5507 5515	01/18/17
T532	Datetime 5544 5557	February 2017
T533	Datetime 5595 5605	March 2017
T534	Datetime 5650 5662	September 13
T535	Datetime 5675 5683	04/09/17
T536	Datetime 5738 5751	November 2018
T537	Datetime 5798 5811	December 2018
T538	MedicationName 5494 5503	tamoxifen
A267	TreatmentContinuityVal T538 finished
A268	TreatmentTypeVal T538 neoadjuvant
A269	TreatmentIntentVal T538 curative
A270	TreatmentCategory T538 AntiNeoPlastics
T539	MedicationName 5523 5530	zoladex
A271	TreatmentContinuityVal T539 continuing
A272	TreatmentTypeVal T539 others
A273	TreatmentIntentVal T539 others
A274	TreatmentCategory T539 Supportive
T540	MedicationName 5571 5580	tamoxifen
A275	TreatmentContinuityVal T540 finished
A276	TreatmentTypeVal T540 neoadjuvant
A277	TreatmentIntentVal T540 curative
A278	TreatmentCategory T540 AntiNeoPlastics
T541	MedicationName 5584 5593	letrozole
A279	TreatmentContinuityVal T541 finished
A280	TreatmentTypeVal T541 neoadjuvant
A281	TreatmentIntentVal T541 curative
A282	TreatmentCategory T541 AntiNeoPlastics
T542	MedicationName 5611 5620	letrozole
A283	TreatmentContinuityVal T542 finished
A284	TreatmentTypeVal T542 neoadjuvant
A285	TreatmentIntentVal T542 curative
A286	TreatmentCategory T542 AntiNeoPlastics
T543	MedicationName 5640 5649	tamoxifen
A287	TreatmentContinuityVal T543 finished
A288	TreatmentTypeVal T543 neoadjuvant
A289	TreatmentIntentVal T543 curative
A290	TreatmentCategory T543 AntiNeoPlastics
T544	MedicationName 5782 5794	OS/letrozole
A291	TreatmentContinuityVal T544 finished
A292	TreatmentTypeVal T544 adjuvant
A293	TreatmentIntentVal T544 curative
A294	TreatmentCategory T544 AntiNeoPlastics
T545	MedicationName 5761 5770	tamoxifen
A295	TreatmentContinuityVal T545 finished
A296	TreatmentTypeVal T545 adjuvant
A297	TreatmentIntentVal T545 curative
A298	TreatmentCategory T545 AntiNeoPlastics
T546	MedicationName 5827 5835	letrozle
A299	TreatmentContinuityVal T546 finished
A300	TreatmentTypeVal T546 adjuvant
A301	TreatmentIntentVal T546 curative
A302	TreatmentCategory T546 AntiNeoPlastics
T547	MedicationName 5839 5849	exemestane
A303	TreatmentContinuityVal T547 finished
A304	TreatmentTypeVal T547 adjuvant
A305	TreatmentIntentVal T547 curative
A306	TreatmentCategory T547 AntiNeoPlastics
R146	BeginsOnOrAt Arg1:T530 Arg2:T538	
R147	BeginsOnOrAt Arg1:T531 Arg2:T539	
R148	EndsOnOrAt Arg1:T532 Arg2:T540	
R149	BeginsOnOrAt Arg1:T532 Arg2:T541	
R150	EndsOnOrAt Arg1:T533 Arg2:T542	
R151	BeginsOnOrAt Arg1:T533 Arg2:T543	
A307	IsPresentOnFirstCancerDiagnosis T146 no
A308	IsCausedByDiagnosedCancer T146 unclear
A309	ChronicVal T146 non-chronic
A310	ContinuityVal T146 new
R152	BeginsOnOrAt Arg1:T534 Arg2:T146	
T548	ProcedureName 5696 5708	mastectomies
A311	IntentVal T548 treatment-curative
A312	TreatmentTypeVal T548 local
A313	TreatmentCategory T548 Others
A314	IsTumorRemaining T548 no
T549	Laterality 5686 5695	bilateral
R153	HappensAtOnDuring Arg1:T535 Arg2:T548	
T550	ProcedureName 5713 5722	left slnb
A315	IntentVal T550 staging
R154	HappensAtOnDuring Arg1:T550 Arg2:T535	
R155	EndsOnOrAt Arg1:T536 Arg2:T545	
R156	BeginsOnOrAt Arg1:T536 Arg2:T544	
R157	EndsOnOrAt Arg1:T537 Arg2:T546	
R158	BeginsOnOrAt Arg1:T537 Arg2:T547	
A316	IsPresentOnFirstCancerDiagnosis T152 no
A317	IsCausedByDiagnosedCancer T152 no
A318	ChronicVal T152 non-chronic
A319	ContinuityVal T152 unclear
A320	IsPresentOnFirstCancerDiagnosis T153 no
A321	IsCausedByDiagnosedCancer T153 no
A322	ChronicVal T153 non-chronic
A323	ContinuityVal T153 unclear
A324	TreatmentContinuityVal T154 continuing
A325	TreatmentTypeVal T154 local
R159	TreatmentDiscontinuedBecauseOf Therapy:T546 Reason:T152	
R160	TreatmentDiscontinuedBecauseOf Therapy:T546 Reason:T153	
R161	ConditionOrTreatmentCausesProblem Treatment:T546 Prob:T152	
R162	ConditionOrTreatmentCausesProblem Treatment:T546 Prob:T153	
A326	ChronicVal T155 non-chronic
A327	ContinuityVal T155 unclear
T551	Datetime 5947 5957	12/26/2016
R163	BeginsOnOrAt Arg1:T155 Arg2:T551	
T552	Symptom 6004 6014	amenorrhea
A328	IsPresentOnFirstCancerDiagnosis T552 unclear
A329	IsCausedByDiagnosedCancer T552 no
A330	ChronicVal T552 non-chronic
T553	Duration 6023 6032	last year
T554	Frequency 6057 6071	almost monthly
R165	Temporal Arg1:T554 Arg2:T552	
T555	Symptom 6089 6120	pain with ovulation and periods
A333	ContinuityVal T555 worsening
T556	Symptom 6113 6151	periods, they are heavier and clotting
A334	ChronicVal T556 non-chronic
A335	ContinuityVal T556 worsening
T557	ClinicalCondition 6160 6174	Cyst of breast
T558	Datetime 6175 6185	06/16/2015
R166	HappensAtOnDuring Arg1:T557 Arg2:T558	
T559	Symptom 6241 6260	2 left breast lumps
A336	IsPresentOnFirstCancerDiagnosis T559 yes
A337	IsCausedByDiagnosedCancer T559 yes
A338	ChronicVal T559 non-chronic
A339	ContinuityVal T559 worsening
R167	HappensAtOnDuring Arg1:T558 Arg2:T559	
T562	Site 6424 6430	breast
T563	Laterality 6419 6423	left
R168	LateralityOfSite Arg1:T563 Arg2:T562	
T564	Radiology 6431 6441	ultrasound
A341	IntentVal T564 diagnosis
R169	BiomarkerRel Arg1:T318 Arg2:T321	
R170	BiomarkerRel Arg1:T317 Arg2:T320	
R171	BiomarkerRel Arg1:T316 Arg2:T319	
T565	ClinicalCondition 11248 11254	cancer
A342	ChronicVal T565 non-chronic
A343	ContinuityVal T565 stable
T566	Laterality 11236 11240	left
T567	GenomicTest 11256 11266	mammaprint
A344	IntentVal T567 staging
A345	GenomicTestType T567 GeneExpression
T568	GenomicTestResult 11267 11275	low risk
A346	GenomicTestType T568 GeneExpression
R172	ResultOfTest Desc:T568 Test:T567	
T569	Histology 11276 11279	IDC
A347	EpisodeDescription T569 FirstOccurrence
T570	Site 11292 11298	breast
T571	Laterality 11287 11291	left
R173	LateralityOfSite Arg1:T571 Arg2:T570	
T572	TreatmentType 11303 11307	NAHT
A348	TreatmentContinuityVal T572 finished
A349	TreatmentTypeVal T572 neoadjuvant
A350	TreatmentIntentVal T572 curative
T573	MedicationName 11313 11322	tamoxifen
A351	TreatmentContinuityVal T573 finished
A352	TreatmentTypeVal T573 neoadjuvant
A353	TreatmentIntentVal T573 curative
A354	TreatmentCategory T573 AntiNeoPlastics
T574	ProcedureName 11338 11350	mastectomies
A355	IntentVal T574 treatment-curative
A356	TreatmentTypeVal T574 local
A357	TreatmentCategory T574 Others
A358	IsTumorRemaining T574 no
T575	Site 11328 11337	bilateral
T576	MedicationName 11365 11374	tamoxifen
A359	TreatmentTypeVal T576 adjuvant
A360	TreatmentIntentVal T576 curative
A361	TreatmentCategory T576 AntiNeoPlastics
T577	MedicationName 11412 11424	OS/letrozole
A362	TreatmentTypeVal T577 adjuvant
A363	TreatmentIntentVal T577 curative
A364	TreatmentCategory T577 AntiNeoPlastics
T578	MedicationName 11460 11469	letrozole
A365	TreatmentTypeVal T578 adjuvant
A366	TreatmentIntentVal T578 curative
A367	TreatmentCategory T578 AntiNeoPlastics
T579	MedicationName 11473 11483	exemestane
A368	TreatmentTypeVal T579 adjuvant
A369	TreatmentIntentVal T579 curative
A370	TreatmentCategory T579 AntiNeoPlastics
T580	Datetime 11428 11441	November 2018
R174	EndsOnOrAt Arg1:T576 Arg2:T580	
R175	BeginsOnOrAt Arg1:T577 Arg2:T580	
T581	Datetime 11487 11500	December 2018
R176	EndsOnOrAt Arg1:T578 Arg2:T581	
R177	EndsOnOrAt Arg1:T579 Arg2:T581	
T582	Symptom 11508 11515	anxiety
A371	IsPresentOnFirstCancerDiagnosis T582 no
A372	IsCausedByDiagnosedCancer T582 no
A373	ChronicVal T582 non-chronic
A374	ContinuityVal T582 unclear
T583	Symptom 11520 11538	emotional lability
A375	IsPresentOnFirstCancerDiagnosis T583 no
A376	IsCausedByDiagnosedCancer T583 no
A377	ChronicVal T583 non-chronic
A378	ContinuityVal T583 unclear
R178	TreatmentDiscontinuedBecauseOf Therapy:T578 Reason:T582	
R179	ConditionOrTreatmentCausesProblem Treatment:T578 Prob:T582	
R180	TreatmentDiscontinuedBecauseOf Therapy:T579 Reason:T583	
R181	ConditionOrTreatmentCausesProblem Treatment:T579 Prob:T583	
T584	MedicationName 11588 11598	exemestane
A379	TreatmentContinuityVal T584 continuing
A380	TreatmentTypeVal T584 adjuvant
A381	TreatmentIntentVal T584 curative
A382	TreatmentCategory T584 AntiNeoPlastics
T585	MedicationModifier 11599 11603	25mg
R182	TreatmentDesc Therapy:T585 Desc:T584	
T586	TreatmentType 11635 11637	AI
A383	NegationModalityVal T586 planned_in_future
A384	TreatmentTypeVal T586 adjuvant
A385	TreatmentIntentVal T586 curative
T587	Duration 11651 11658	5 years
R183	HappensAtOnDuring Arg1:T586 Arg2:T587	
T588	DiagnosticLabTest 11682 11697	estradiol level
A387	IntentVal T292 screening
T589	Frequency 11788 11801	every 2 years
R184	Temporal Arg1:T292 Arg2:T589	
T590	TreatmentType 11839 11853	bisphosphonate
A389	NegationModalityVal T590 hypothetical_in_future
A390	TreatmentTypeVal T590 others
T591	TreatmentType 11873 11887	bisphosphonate
A391	NegationModalityVal T591 hypothetical_in_future
A392	TreatmentTypeVal T591 others
T592	TreatmentType 11974 11988	bisphosphonate
A393	NegationModalityVal T592 hypothetical_in_future
A394	TreatmentTypeVal T592 others
T593	Metastasis 11917 11921	mets
A395	NegationModalityVal T593 hypothetical_in_future
A396	NegationModalityVal T299 hypothetical_in_future
T594	ClinicalCondition 12076 12085	menopause
A397	NegationModalityVal T594 hypothetical_in_future
A398	ChronicVal T594 non-chronic
T595	Duration 12092 12099	5 years
T596	TreatmentType 12103 12108	OS/AI
A400	NegationModalityVal T596 hypothetical_in_future
A401	NegationModalityVal T302 negated
A402	IsPresentOnFirstCancerDiagnosis T304 no
A403	IsCausedByDiagnosedCancer T304 no
A404	ChronicVal T304 non-chronic
A405	ContinuityVal T304 improving
T597	Symptom 12194 12201	Anxiety
A406	IsPresentOnFirstCancerDiagnosis T597 no
A407	IsCausedByDiagnosedCancer T597 no
A408	ChronicVal T597 non-chronic
A409	ContinuityVal T597 improving
T598	ClinicalCondition 8546 8562	Anxiety disorder
A410	ChronicVal T598 chronic
A411	ContinuityVal T598 unclear
T599	ProcedureName 8284 8291	rolfing
A412	IntentVal T599 unclear
A413	TreatmentTypeVal T599 others
A414	TreatmentCategory T599 Others
T600	TreatmentType 8319 8334	muscle relaxers
A415	NegationModalityVal T600 hypothetical_in_future
A416	TreatmentTypeVal T600 others
A417	TreatmentIntentVal T600 unclear
A418	IsPresentOnFirstCancerDiagnosis T201 no
A419	IsCausedByDiagnosedCancer T201 no
A420	ContinuityVal T201 unclear
T601	Symptom 8380 8388	tingling
A421	IsPresentOnFirstCancerDiagnosis T601 no
A422	IsCausedByDiagnosedCancer T601 no
A423	ContinuityVal T601 unclear
T602	Site 8397 8400	arm
T603	Laterality 8392 8396	left
R186	LateralityOfSite Arg1:T603 Arg2:T602	
R187	SiteOf Arg1:T602 Arg2:T601	
R188	SiteOf Arg1:T602 Arg2:T201	
T604	Symptom 8407 8434	hand will shake with weight
T605	Symptom 8197 8201	pain
A424	ContinuityVal T605 stable
T606	Site 8192 8196	neck
T607	Site 8220 8228	shoulder
T608	Laterality 8215 8219	left
R189	LateralityOfSite Arg1:T608 Arg2:T607	
R190	LateralityOfSite Arg1:T608 Arg2:T606	
R191	SiteOf Arg1:T606 Arg2:T605	
R192	SiteOf Arg1:T607 Arg2:T605	
T609	Datetime 8032 8042	05/12/2015
T610	Symptom 8027 8031	pain
T611	Site 8022 8026	Neck
R193	BeginsOnOrAt Arg1:T609 Arg2:T610	
R194	SiteOf Arg1:T611 Arg2:T610	
A425	NegationModalityVal T193 negated
T612	Site 8009 8015	breast
T613	Laterality 8004 8008	left
R195	LateralityOfSite Arg1:T613 Arg2:T612	
T614	Symptom 7993 8003	discomfort
R196	SiteOf Arg1:T612 Arg2:T614	
T615	Symptom 7946 7951	lumps
A426	IsPresentOnFirstCancerDiagnosis T615 yes
A427	IsCausedByDiagnosedCancer T615 yes
A428	ChronicVal T615 non-chronic
A429	ContinuityVal T615 new
T616	Site 7957 7963	breast
T617	Laterality 7952 7956	left
R197	LateralityOfSite Arg1:T617 Arg2:T616	
R198	SiteOf Arg1:T616 Arg2:T615	
T618	Symptom 12337 12345	symptoms
A430	NegationModalityVal T618 hypothetical_in_future
A431	NegationModalityVal T293 hypothetical_in_future
A432	ContinuityVal T287 stable
T619	Age 11201 11203	49
T620	Frequency 11604 11609	daily
R199	Temporal Arg1:T620 Arg2:T584	
T11	SectionSkip 9617 9772	ALLERGIES    Allergies/Contraindications   Allergen Reactions    Latex Hives    Venom-Honey Bee Anaphylaxis    Penicillins Hives    Codeine Nausea Only
A435	SectionSkipType T11 allergies
T12	SectionSkip 9779 9833;9838 11132	PHYSICAL EXAM  Vital signs:   Vitals:    01/21/19 1252 BP: 117/66   Pulse: 75   Resp: 18   Temp: 37 C (98.6 F)   TempSrc: Temporal   SpO2: 100%   Weight: 64.2 kg (141 lb 9.6 oz)   Height: 162.9 cm (5' 4.13")     ECOG: 0  Physical Examination: General appearance - alert, well appearing, and in no distress  Mental status - alert, oriented to person, place, and time  Eyes - pupils equal and reactive, extraocular eye movements intact  Mouth - mucous membranes moist, pharynx normal without lesions  Neck - supple, no significant adenopathy  Lymphatics - no suspicious cervical, SC, axillary lymphadenopathy  Chest - clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry  Heart - normal rate, regular rhythm, normal S1, S2, no murmurs, rubs, clicks or gallops  Abdomen - soft, nontender, nondistended, no masses or organomegaly  Breasts -s/p bilateral mastectomies with implants. No suspicious masses, nodules, rashes bilaterally   Back exam - full range of motion, no tenderness, palpable spasm or pain on motion  Neurological - alert, oriented, normal speech, no focal findings or movement disorder noted  Musculoskeletal - no joint tenderness, deformity or swelling  Extremities - peripheral pulses normal, no pedal edema, no clubbing or cyanosis  Skin - normal coloration and turgor, no rashes, no suspicious skin lesions noted
A436	SectionSkipType T12 physical_exam
T7	SectionSkip 6444 7885;7888 7915	COMPARISON: 11/26/14 and 06/01/09.  FINDINGS:  3 views of the left breast were obtained.  The breast tissue is extremely dense.  There are is a large rounded benign-appearing nodule in the inferior medial periareolar region of the left breast at the site of one lump.  There is dense breast parenchyma in the lateral mid anterior portion of the left breast at the site of a second lump which was marked.  No spiculated mass or suspicious calcification is identified.  Limited left breast ultrasound: There is a large cyst containing one thin partial septation located at the 10:30 position 1 cm from the nipple measuring 3.9 x 3.0 x 2.1 cm. This accounts for one of the 2 palpable nodules.  There is a small simple cyst at the 3:00 position 3 cm from the nipple measuring 4.2 x 3.8 x 3.3 mm. This accounts for the second palpable nodule.  No solid nodule is present.  IMPRESSION:  1. 2 simple cysts in the left breast accounting for the palpable abnormalities.  2. Cyst aspiration of the larger cyst could be performed if pain persists.  3. If symptoms resolve routine bilateral followup mammography in November 2015 is recommended.  The results were given to the patient at the time of visit.      Mass of breast 05/12/2015     Last Assessment & Plan:   mammo done November 2014.      1. BREASTS ARE EXTREMELY DENSE, WHICH LOWERS SENSITIVITY OF MAMMOGRAPHY. NO GROSS EVIDENCE OF MALIGNANCY AND NO INTERVAL CHANGE.    2. SCREENING MAMMOGRAM IN ONE YEAR IS RECOMMENDED.
A340	SectionSkipType T7 radiology_report
T8	Site 6335 6339	LEFT
T13	Radiology 6359 6370	mammography
A437	IntentVal T13 diagnosis
R200	SiteOf Arg1:T8 Arg2:T13	
R185	HappensAfter Arg1:T594 Arg2:T595	
R201	HappensBefore Arg1:T596 Arg2:T595	
R164	HappensAtOnDuring Arg1:T552 Arg2:T553	
A438	TreatmentContinuityVal T578 discontinued_early
A439	TreatmentContinuityVal T579 continuing
T560	Site 70 76	breast
R202	SiteOf Arg1:T560 Arg2:T325	
R203	LateralityOfSite Arg1:T332 Arg2:T560	
R204	TumorDesc TumorDetails:T325 Desc:T313	
R205	TumorDesc TumorDetails:T325 Desc:T315	
R206	TumorDesc TumorDetails:T325 Desc:T313	
R207	SiteOf Arg1:T560 Arg2:T314	
R4	ResultOfTest Desc:T339 Test:T338	
R208	TumorDesc TumorDetails:T325 Desc:T340	
T561	Site 899 905	Breast
R209	SiteOf Arg1:T561 Arg2:T326	
R210	SiteOf Arg1:T335 Arg2:T374	
R211	SiteOf Arg1:T336 Arg2:T375	
T621	Site 1574 1580	Breast
R212	LateralityOfSite Arg1:T337 Arg2:T621	
R213	SiteOf Arg1:T621 Arg2:T330	
R214	TumorDesc TumorDetails:T331 Desc:T385	
R215	TumorDesc TumorDetails:T331 Desc:T386	
R216	TumorDesc TumorDetails:T331 Desc:T387	
R217	TumorDesc TumorDetails:T331 Desc:T390	
R218	TestOrProcedureReveals Test:T392 Desc:T422	
R219	TestOrProcedureReveals Test:T392 Desc:T423	
R220	TestOrProcedureReveals Test:T425 Desc:T431	
R221	TestOrProcedureReveals Test:T425 Desc:T432	
T622	Site 2166 2175	Bilateral
R222	SiteOf Arg1:T622 Arg2:T425	
R223	TumorDesc TumorDetails:T565 Desc:T316	
R224	TumorDesc TumorDetails:T565 Desc:T318	
R225	TumorDesc TumorDetails:T565 Desc:T317	
T623	Site 11241 11247	breast
R226	SiteOf Arg1:T623 Arg2:T565	
R227	TumorDesc TumorDetails:T565 Desc:T569	
R228	SiteOf Arg1:T575 Arg2:T574	
R229	SiteOf Arg1:T570 Arg2:T567	
T624	Site 11549 11555	Breast
R230	SiteOf Arg1:T624 Arg2:T287	
R231	TreatmentAdministeredForProblem Treatment:T590 Prob:T293	
T625	Site 11909 11916	distant
R232	SiteOf Arg1:T625 Arg2:T593	
R233	TreatmentAdministeredForProblem Treatment:T584 Prob:T287	
R234	TreatmentAdministeredForProblem Treatment:T586 Prob:T287	
A440	NegationModalityVal T588 hypothetical_in_future
A441	NegationModalityVal T292 planned_in_future
T626	DiseaseState 11901 11908	reduced
A442	ExperiencerVal T593 others
T627	ProcedureName 12164 12176	mastectomies
T628	Site 12154 12163	bilateral
R235	SiteOf Arg1:T628 Arg2:T627	
R236	NotUndergoneBecauseOf Arg1:T302 Reason:T627	
T3	ClinicalCondition 11708 11727	ovarian suppression
A443	NegationModalityVal T3 hypothetical_in_future
A444	ChronicVal T3 non-chronic
R237	ConditionOrTreatmentCausesProblem Treatment:T586 Prob:T3	
A445	NegationModalityVal T626 hypothetical_in_future
R239	SizeOf Arg1:T422 Arg2:T416	
R240	SizeOf Arg1:T423 Arg2:T424	
R241	SizeOf Arg1:T429 Arg2:T430	
R242	SizeOf Arg1:T431 Arg2:T439	
R243	SizeOf Arg1:T432 Arg2:T438	
R244	SizeOf Arg1:T445 Arg2:T446	
R245	SizeOf Arg1:T433 Arg2:T471	
R246	SizeOf Arg1:T485 Arg2:T506	
R247	SizeOf Arg1:T509 Arg2:T508	
R248	SizeOf Arg1:T434 Arg2:T475	
T6	hpi_start 0 10	SUBJECTIVE
T629	ap_start 11165 11175	ASSESSMENT
T630	ap_end 12345 12346	.
T631	hpi_end 758 765	changes
T632	Datetime 396 402	August
R238	BeginsOnOrAt Arg1:T632 Arg2:T352	
